Kristalose Agreement Sample Contracts

Certain portions of this document have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. THIRD AMENDMENT TO KRISTALOSE AGREEMENT

Kristalose Agreement • May 12th, 2009 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations

• Contract Type
  Kristalose Agreement
• Filed
  May 12th, 2009
• Company
  Cumberland Pharmaceuticals Inc
• Industry
  Pharmaceutical preparations

This Third Amendment to Kristalose Agreement (the “Third Amendment”) is entered into this 6th day of April, 2009 by and between Inalco S.P.A. (“Inalco Italy”), Inalco Biochemicals, Inc. (“Inalco U.S.”) and Cumberland Pharmaceuticals Inc. (“Cumberland”). Inalco Italy and Inalco U.S. are hereinafter collectively referred to as “Inalco.”

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. SECOND AMENDMENT TO KRISTALOSE AGREEMENT

Kristalose Agreement • August 12th, 2008 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations

• Contract Type
  Kristalose Agreement
• Filed
  August 12th, 2008
• Company
  Cumberland Pharmaceuticals Inc
• Industry
  Pharmaceutical preparations

This Second Amendment to Kristalose Agreement (the “Amendment”) is entered into this 1st day of July, 2008 by and between Inalco S.P.A. (“Inalco Italy”), Inalco Biochemicals, Inc. (“Inalco U.S.”) and Cumberland Pharmaceuticals Inc. (“Cumberland”). Inalco Italy and Inalco U.S. are hereinafter collectively referred to as “Inalco.”

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. AMENDMENT TO KRISTALOSE AGREEMENT

Kristalose Agreement • May 21st, 2008 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations

• Contract Type
  Kristalose Agreement
• Filed
  May 21st, 2008
• Company
  Cumberland Pharmaceuticals Inc
• Industry
  Pharmaceutical preparations

This Amendment to Kristalose Agreement (the “Amendment”) is entered into this 3rd day of April, 2008 by and between Inalco S.P.A. (“Inalco Italy”), Inalco Biochemicals, Inc. (“Inalco U.S.”) and Cumberland Pharmaceuticals Inc. (“Cumberland”). Inalco Italy and Inalco U.S. are hereinafter collectively referred to as “Inalco.”

Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. FOURTH AMENDMENT TO KRISTALOSE AGREEMENT

Kristalose Agreement • May 17th, 2010 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations

• Contract Type
  Kristalose Agreement
• Filed
  May 17th, 2010
• Company
  Cumberland Pharmaceuticals Inc
• Industry
  Pharmaceutical preparations

This Fourth Amendment to Kristalose Agreement (the “Fourth Amendment”) is effective this 1st day of January, 2010 by and between Inalco S.P.A. (“Inalco Italy”), Inalco Biochemicals, Inc. (“Inalco U.S.”) and Cumberland Pharmaceuticals Inc. (“Cumberland”). Inalco Italy and Inalco U.S. are hereinafter collectively referred to as “Inalco.”